Old Web
English
Sign In
Acemap
>
Paper
>
A costing study of bortezomib shows equivalence of its real‐world costs to conventional treatment
A costing study of bortezomib shows equivalence of its real‐world costs to conventional treatment
2020
Jane F. Thompson
Zoe Teh
Yiyang Chen
Joanne Gardiner
Jana Bednarz
Geoffrey N. Thompson
Cindy Lee
Noemi Horvath
Peter G Bardy
David T. Yeung
Keywords:
Activity-based costing
Immunology
Medicine
Bortezomib
Conventional treatment
Intensive care medicine
Equivalence (measure theory)
novel agents
cost of illness
Correction
Source
Cite
Save
Machine Reading By IdeaReader
11
References
0
Citations
NaN
KQI
[]